Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Neurooncol. 2007 Mar;82(1):81-3. Epub 2006 Aug 31.

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.

Author information

  • 1Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-0804, USA. ChambeMC@moffitt.usf.edu

Abstract

Concurrent temozolomide (TMZ) and radiotherapy is the new standard of care for patients with newly diagnosed glioblastoma. In 51 consecutive patients treated according to this regimen, 7 patients (14%) manifested surgically confirmed early necrosis without evidence of recurrent tumor. This observation suggests that daily TMZ may represent a potent radiosensitizing regimen.

PMID:
16944309
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk